![Right Dose for Accurate Diagnosis: Track Radiation Dose to Patients and Use Diagnostic Reference Levels | IAEA Right Dose for Accurate Diagnosis: Track Radiation Dose to Patients and Use Diagnostic Reference Levels | IAEA](https://www.iaea.org/sites/default/files/styles/original_image_size/public/16/06/pdm_1140x640.jpg?itok=ObfshSDA)
Right Dose for Accurate Diagnosis: Track Radiation Dose to Patients and Use Diagnostic Reference Levels | IAEA
![PDF) AutoFoci, an automated high-throughput foci detection approach for analyzing low-dose DNA double-strand break repair PDF) AutoFoci, an automated high-throughput foci detection approach for analyzing low-dose DNA double-strand break repair](https://i1.rgstatic.net/publication/329154139_AutoFoci_an_automated_high-throughput_foci_detection_approach_for_analyzing_low-dose_DNA_double-strand_break_repair/links/5bf8326fa6fdcc5388154e60/largepreview.png)
PDF) AutoFoci, an automated high-throughput foci detection approach for analyzing low-dose DNA double-strand break repair
![A medical staff member of the Melopee residence receives a dose of the Pfizer-BioNTech COVID-19 vaccine, as part of the coronavirus disease (COVID-19) vaccination campaign, in Brussels, Belgium January 13, 2021. REUTERS/Johanna A medical staff member of the Melopee residence receives a dose of the Pfizer-BioNTech COVID-19 vaccine, as part of the coronavirus disease (COVID-19) vaccination campaign, in Brussels, Belgium January 13, 2021. REUTERS/Johanna](https://c8.alamy.com/comp/2E2AMEM/a-medical-staff-member-of-the-melopee-residence-receives-a-dose-of-the-pfizer-biontech-covid-19-vaccine-as-part-of-the-coronavirus-disease-covid-19-vaccination-campaign-in-brussels-belgium-january-13-2021-reutersjohanna-geron-2E2AMEM.jpg)
A medical staff member of the Melopee residence receives a dose of the Pfizer-BioNTech COVID-19 vaccine, as part of the coronavirus disease (COVID-19) vaccination campaign, in Brussels, Belgium January 13, 2021. REUTERS/Johanna
![Mingxuan Xu, Ph. D. on Twitter: "(PROCLAIM-CX-072): an open-label dose-finding and first-in-human study https://t.co/Klrf0qDEI8 by @ANaingMD et al published @jitcancer @sitcancer c/c @OncoAlert https://t.co/bUs8NM8Esl" / Twitter Mingxuan Xu, Ph. D. on Twitter: "(PROCLAIM-CX-072): an open-label dose-finding and first-in-human study https://t.co/Klrf0qDEI8 by @ANaingMD et al published @jitcancer @sitcancer c/c @OncoAlert https://t.co/bUs8NM8Esl" / Twitter](https://pbs.twimg.com/media/E7FrpdXWUAAvZ7x.jpg)